Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV
February 7th, 2020
Tag: Vaccines
Applied DNA Sciences Reports 14 Development Customers for its Linear DNA Manufacturing Platform
November 25th, 2019
‘Linear DNA’ Combo Shows Punch In Cancer Fight
September 20th, 2019
Applied DNA Subsidiary LineaRx and Takis/Evvivax Progress Linear DNA for Use as Cancer Vaccine Candidates
March 1st, 2019
LineaRx agreement with Takis and Evvivax for cancer vaccines
September 21st, 2018
Pharmaceutical Technology | LineaRx signs drug development agreement with Takis
September 21st, 2018
LineaRx to Collaborate with Takis and Evvivax on Cancer Vaccines
September 20th, 2018
Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
September 20th, 2018
APDN’s CRO/CMO milestones in research/mfg of Linear DNA
August 3rd, 2018